Trulicity® (dulaglutide) – Expanded indication
November 17, 2022 - The FDA approved Eli Lilly’s Trulicity (dulaglutide), as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus (T2DM).
Download PDF
